Skip to main content

Table 3 Conflict of interest policies and practices in key public pharmaceutical committees in SEAR countries

From: Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region

 

Regulation

Selection

Pricing

Public procurement

Bangladesh

Quality Policy exists [33]

No information [34]

No information

Procurement Rules and Code of Ethics exists [25]

Individual written COI declaration

Collective declaration of impartiality

Replacement of members with COI

Prohibition of gifts, payments, hospitality to members

Debarment for violation of COI rules

Bhutan

Defines COI [28, 29]

Individual written COI declaration prior to all meetings [29]

Members with COI must abstain from relevant work [29]

Members avail themselves of remuneration for attending meetings [29]

Oversight of policy implementation by Anti-Corruption Commission

Civil servants prohibited from:

Working in private sector

Accepting meals from the private sector

Individual written COI declaration prior to all meetings

Replacement or recusal of members with COI

Oversight of policy implementation by Anti-Corruption Commission

Civil servants prohibited from:

Working in private sector

Accepting meals from the private sector

Individual written COI declaration prior to all meetings

Replacement or recusal of members with COI

Oversight of policy implementation by Anti-Corruption Commission

Civil servants prohibited from:

Working in private sector

Accepting meals from the private sector

Procurement Rules and declaration form [26]

Individual written COI declaration prior to all meetings

Replacement or recusal of members with COI

Disclosure verified by procuring agency

Members sign Integrity Pact [35]

Prohibition of bribes, consideration, gifts, rewards, favours, or any other material or immaterial benefit or advantage

Tender process is open and transparent

Grievances mechanism

Oversight of policy implementation by Anti-Corruption Commission

Civil servants prohibited from:

Working in private sector

Accepting meals from the private sector

DPRK

No information

No information

No information

No information

India

Individual written COI declaration [22]

Subject experts selected from expert bank [36]

Individual written COI declaration [31, 32]

No information [37]

Individual written COI declaration

N/A – largely at the state level

Indonesia

Individual written COI declaration on annual basis

Individuals with COI are recused from drug evaluation and committee meetings

Transparent, evidence-based process for medicines selection [38]

Individual written COI declaration

Pharmaceutical industry cannot submit formulary requests directly

Excludes pharmaceutical industry employees and representatives

Individual written COI declaration

No information

Maldives

Transparency guideline exists [39]

Individual written COI declaration

Members with COI must abstain from relevant work

Agreement to abstain from private sector employment

Civil servants are provided a non-practice

No information [40, 41]

N/A – responsibility of regulatory staff

No information

Myanmar

No information

No information [42]

No information

No information

Nepal

Civil servants not allowed to work in private sector

Civil servants not allowed to work in private sector

Industry representatives must declare COI and abstain from relevant work

Public procurement Code of Conduct [43]

Bidders and consultants must provide written COI declaration

Prohibits inducements to procurement officials

Officials must refrain from COI

Officials cannot work for an entity with which they have had procurement dealings until 2 years after retirement

Recusal of officials from procurement proceedings where family members are involved

Public Procurement Monitoring Office provides oversight and enforcement

Sri Lanka

Code of Conduct present

Terms of reference exist [30]

COI defined

Individual written COI disclosure upon selection and from ‘time to time’ thereafter

Disclosures recorded in committee minutes

Committee members ‘should not’ have any COI

Members with COI must abstain from relevant decision-making or other work

No employment by pharmaceutical industry 3 years prior or 3 years following membership

Subject matter experts do not have voting rights

None

Individual written COI disclosure required

Individual written COI disclosure required

Thailand

Individual written COI disclosure required [44]

Disclosures verified by secretariat

Codes of ethics for medicines selection processes

Excludes pharmaceutical industry employees, owners and executives

Individual written COI disclosure required for NLEM working group experts, [45] secretariat and NLEM subcommittee during committee development and at each meeting

NLEM members with any business interest in the medicine or intervention must abstain from relevant decision-making

HITAP members must annually declare COI [46]

HITAP members prohibited from receiving financial benefits from private, for-profit companies based on the organisation’s codes of conduct [46]

COI policy is regularly reviewed and revised as needed

Individual written COI disclosure required [15]

N/A – procurement largely de-centralised

Timor-Leste

No information [47]

Transparent decision-making processes [48, 49]

No information

Anti-corruption commission provides oversight

  1. Information in this table is based on a review of policies that are publicly available in English, review of secondary literature sources and analysis of key informant interviews (in italics)